Literature DB >> 31617450

Mitigation of Primary Graft Dysfunction in Lung Transplantation: Current Understanding and Hopes for the Future.

Barbara J Wilkey1, Benjamin A Abrams1.   

Abstract

Primary graft dysfunction (PGD) is a form of acute lung injury that develops within the first 72 hours after lung transplantation. The overall incidence of PGD is estimated to be around 30%, and the 30-day mortality for grade 3 PGD around 36%. PGD is also associated with the development of bronchiolitis obliterans syndrome, a specific form of chronic lung allograft dysfunction. In this article, we will discuss perioperative strategies for PGD prevention as well as possible future avenues for prevention and treatment.

Entities:  

Keywords:  cardiac anesthesia; cardiopulmonary bypass surgery; lung transplantation; primary graft dysfunction; thoracic surgery; transplantation

Year:  2019        PMID: 31617450     DOI: 10.1177/1089253219881980

Source DB:  PubMed          Journal:  Semin Cardiothorac Vasc Anesth        ISSN: 1089-2532


  4 in total

Review 1.  Extracellular Vesicles Mediate Immune Responses to Tissue-Associated Self-Antigens: Role in Solid Organ Transplantations.

Authors:  Ranjithkumar Ravichandran; Sandhya Bansal; Mohammad Rahman; Angara Sureshbabu; Narendra Sankpal; Timothy Fleming; Ankit Bharat; Thalachallour Mohanakumar
Journal:  Front Immunol       Date:  2022-04-27       Impact factor: 8.786

Review 2.  Mesenchymal Stromal/Stem Cells and Their Products as a Therapeutic Tool to Advance Lung Transplantation.

Authors:  Vitale Miceli; Alessandro Bertani
Journal:  Cells       Date:  2022-02-27       Impact factor: 6.600

Review 3.  Graft dysfunction and rejection of lung transplant, a review on diagnosis and management.

Authors:  Haishuang Sun; Mei Deng; Wenhui Chen; Min Liu; Huaping Dai; Chen Wang
Journal:  Clin Respir J       Date:  2022-01-25       Impact factor: 1.761

4.  IL-1β-dependent extravasation of preexisting lung-restricted autoantibodies during lung transplantation activates complement and mediates primary graft dysfunction.

Authors:  Wenbin Yang; Emily Jeong Cerier; Félix L Núñez-Santana; Qiang Wu; Yuanqing Yan; Chitaru Kurihara; Xianpeng Liu; Anjana Yeldandi; Nigar Khurram; Diego Avella-Patino; Haiying Sun; G R Scott Budinger; Daniel Kreisel; Thalachallour Mohanakumar; Emilia Lecuona; Ankit Bharat
Journal:  J Clin Invest       Date:  2022-10-17       Impact factor: 19.456

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.